BioCryst Pharmaceuticals
BCRX
BCRX
88 hedge funds and large institutions have $461M invested in BioCryst Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more funds holding
Funds holding: 75 → 88 (+13)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
88
Holding in Top 10
2
Calls
$10.9M
Puts
$7.64M
Top Buyers
| 1 | +$67.6M | |
| 2 | +$16.7M | |
| 3 | +$16.7M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$9.52M |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$3.19M |
Top Sellers
| 1 | -$8.81M | |
| 2 | -$8.16M | |
| 3 | -$3.93M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$3.8M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$2.22M |